Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2012
10/18/2012WO2012140214A1 IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
10/18/2012WO2012140132A1 Nutritional compositions including branched chain fatty acids for improving gut barrier function
10/18/2012WO2012140031A1 Lactobacillus paracasei ncc2461 (st11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
10/18/2012WO2012140020A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012WO2012139930A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
10/18/2012WO2012139225A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
10/18/2012WO2012111997A3 Cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory t-cells as active ingredient
10/18/2012WO2012099441A3 Immune response inhibiting composition containing stem cells expressing tryptophan metabolizing enzyme genes
10/18/2012US20120266262 Methods and compositions relating to zpa polypeptides
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264812 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
10/18/2012US20120264809 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
10/18/2012US20120264792 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264759 Benzyl substituted triazine derivatives and their therapeutical applications
10/18/2012US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
10/18/2012US20120264732 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264730 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264729 Co-crystals and salts of ccr3-inhibitors
10/18/2012US20120264719 Dosage regimen of an s1p receptor modulator
10/18/2012US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264714 Boron-containing small molecules as anti-inflammatory agents
10/18/2012US20120264698 Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263766 Formulations
10/18/2012US20120263765 Agents from cells
10/18/2012US20120263758 Pet food compositions including probiotics and methods of manufacture and use thereof
10/18/2012US20120263757 Composition and method for diagnosis and immunotherapy of prostate cancer
10/18/2012US20120263755 Methods and compositions for eliciting an immune response against hepatitis b virus
10/18/2012US20120263754 Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines
10/18/2012US20120263753 Benzonaphthyridine-containing vaccines
10/18/2012US20120263750 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites
10/18/2012US20120263749 Polyvalent conjugate vaccine for cancer
10/18/2012US20120263748 Superior Molecular Vaccine Linking the Translocation Domain of a Bacterial Toxin to an Antigen
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263745 Antichlamydial agents
10/18/2012US20120263743 Influenza hemagglutinin compositions and uses thereof
10/18/2012US20120263742 Combination of Protein Forms for Hornfly Vaccination
10/18/2012US20120263741 Variants of the major allergen phl p 1 from timothy grass
10/18/2012US20120263740 Aptamer-targeted sirna to inhibit nonsense mediated decay
10/18/2012US20120263738 Multiplex dicer substrate rna interference molecules having joining sequences
10/18/2012US20120263737 Methods for inhibiting allograft rejection
10/18/2012US20120263733 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation
10/18/2012US20120263724 Escherichia coli o157:h7 proteins and uses thereof
10/18/2012US20120263718 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
10/18/2012US20120263714 Substituted halophenoxybenzamide derivatives
10/18/2012US20120263712 Pyrrolidine-1,2-dicarboxamide derivatives
10/18/2012US20120263708 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/2012US20120263695 Composition having strains of lactobacillus fermentum
10/18/2012US20120263691 Modular aptamer-regulated ribozymes
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/18/2012US20120263677 Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
10/18/2012US20120263665 Peptide
10/18/2012US20120263654 Melanoma specific biomarker
10/18/2012US20120263644 Treatment and diagnosis of inflammatory disorders and hiv
10/18/2012DE102011016875A1 Zubereitung enthaltend DISC1 und/oder mindestens ein DISC1-Fragment zur Anwendung bei der therapeutischen Behandlung des menschlichen oder tierischen Körpers Preparation comprising DISC1 and / or at least one DISC1 fragment for use in the therapeutic treatment of the human or animal body
10/18/2012CA2833305A1 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833296A1 Fused imidazole derivatives useful as ido inhibitors
10/18/2012CA2833180A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012CA2832611A1 Methods for inhibiting allograft rejection
10/18/2012CA2831679A1 Nutritional compositions including branched chain fatty acids for improving gut barrier function
10/18/2012CA2830786A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
10/18/2012CA2830204A1 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
10/18/2012CA2829261A1 Lactobacillus paracasei ncc2461 (st11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
10/17/2012EP2511300A2 High affinity human antibodies to human IL-4 receptor
10/17/2012EP2511297A1 Anti-CD38 human antibodies and uses therefor
10/17/2012EP2511275A1 Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
10/17/2012EP2510948A1 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
10/17/2012EP2510940A1 Use of cyr61 protein for preparing medicine
10/17/2012EP2510932A1 Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
10/17/2012EP2510084A1 Stem cell immune modulation methods of use and apparatus
10/17/2012EP2510010A1 Antibodies binding preferentially human csf1r extracellular domain 4 and their use
10/17/2012EP2509957A1 Cysteine protease inhibitors
10/17/2012EP2509956A1 Cysteine protease inhibitors
10/17/2012EP2509943A1 2-methylene-19,26-nor-(20s)-l&-hydroxyvitamin d3
10/17/2012EP2509615A1 Novel cyclic peptides
10/17/2012EP2509429A1 Infant formula with probiotics and milk fat globule membrane components
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741227A Aryl benzylamine compounds
10/17/2012CN102740872A Methods and compositions for providing protective immunity in the elderly
10/17/2012CN102740860A Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
10/17/2012CN102740844A Combination of droloxifene and clopidogrel
10/17/2012CN102740714A Method for treatment of lacto-n-biose-containing solution
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102732474A Compound for inhibiting mycobacterium tuberculosis, screening method and uses thereof
10/17/2012CN102732410A Fatigue-resisting immunity-enhancing healthcare wine and method for preparing same
10/17/2012CN102731672A Extraction and preparation process of peony pod polysaccharide
10/17/2012CN102731666A Method for extracting polysaccharide from cordyceps militaris medium
10/17/2012CN102731476A Benzo-cycloheptyl-pyridine derivatives containing cyanoguanidine structure, preparation method, and pharmaceutical compositions and medicinal application thereof
10/17/2012CN102731413A Urea compound and its preparation method, intermediate and use
10/17/2012CN102731379A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
10/17/2012CN102731343A Nitrogen atom-polysubstituted micro-molecular organic aryl amide compounds and derivatives thereof, and application and preparation method thereof
10/17/2012CN102727886A Preparation method of immunostimulatory injection for livestock
10/17/2012CN102727863A Combined drug of compound fermented Cordyceps sinensis powder and ginsenoside Rg1
10/17/2012CN102727861A Treatment of t-cell mediated diseases
10/17/2012CN102727844A Bath traditional Chinese medicinal composition for controlling obesity and enhancing human body resistance
10/17/2012CN102727840A Huolong Dan
10/17/2012CN102727828A Traditional Chinese medicinal composition used for postoperative adjuvant therapy for colorectal cancer
10/17/2012CN102727822A Chinese herbal recovering decoction for blood stasis type patients in operation period
1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 1172